Rob Rubinsky

As Chief Market Access and Patient Experience Officer, Rob Rubinsky is 
responsible for developing and implementing strategies that help reduce 
complexity for patients and improve the overall access experience. 
Rob utilizes deep analytical insights and a patient-first approach to find solutions 
that remove friction and drive breadth, depth, and speed of patient access. He is a 
thought leader, change agent, and adept communicator who relishes the 
opportunity to engage complexity, influence change, and advance access 
strategies for the long-term growth of Novartis in the United States. 
Rob is well known and respected across the pharmaceutical industry for building, 
developing, and leading high-performing teams through transformative 
environments using a data-driven approach with a specific focus on integrity, 
efficiency, and profitability. 
“It is my passion to advocate for collaborative ‘win-win’ 
scenarios that advance the industry, support patients, and 
deliver value to all stakeholders. We know how profoundly 
important it is to help patients seeking access to innovative 
medical therapies that are lifesaving or life changing.” 
Since joining Novartis in 2006, Rob has held leadership roles across different 
departments, driven by the pursuit of ensuring patients can access Novartis 
medicines. With expertise in negotiating, contracting, and gross-to-net 
management, he has positively impacted the areas of portfolio strategy, 
therapeutic and product strategy, commercial access integration, account 
management and pricing, channel strategy, and government and regional 
markets. 
Rob is proud to call New Jersey his home and, when not at work, he cherishes 
spending time with his wife and three daughters.